Clinical trial
Sitagliptin's Effects on Glucose-stimulated Insulin Secretion and Oral Glucose
NCT06813014 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sitagliptin's Effects on Glucose-stimulated Insulin Secretion and Oral Glucose
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- December 31, 2032
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes